Barclays PLC vs Johnson & Johnson — how do they compare? Barclays PLC trades at $28 (market cap $93.87B), while Johnson & Johnson trades at $258.91 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 6.7× Barclays PLC's market cap, and Barclays PLC pays the higher dividend (2.19%). Which is the better fit depends on your goals.
| BCS | JNJ | |
|---|---|---|
Market Cap | $93.87B | $626.09B |
Sector | Financials | Health |
52-Week High | $28.56 | $267.24 |
52-Week Low | $19.36 | $172.78 |
Dividend Yield | 2.19% | 2.06% |
Volume | — | 6,156,228 |
Enterprise Value | — | $654.37B |
Trailing returns across standard periods
Latest headlines on both assets
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →